Tenet Healthcare Corporation
Bear Case (25th pct.)
65.8% vs price
Base Case (Median)
108.4% vs price
Bull Case (75th pct.)
135.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $551.27 | 108.4% | High (40%) |
| PE Comparable | $577.05 | 118.1% | Medium (25%) |
| Growth Trajectory DCF | $699.78 | 164.5% | Medium (20%) |
| Graham Number | $165.26 | -37.5% | Medium (40%) |
| EV/EBITDA | $497.39 | 88.0% | Medium (20%) |
| EV/FCF | $670.66 | 153.5% | Medium (20%) |
| Earnings Power Value | $379.88 | 43.6% | Medium (50%) |
Based on 7 out of 8 methods, THC appears undervalued at the current price of $264.56. The base case fair value of $551.27 implies 108.4% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.